CATAMARAN CORP COM STK (CDA) (CTRX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
INSURANCE AGENTS, BROKERS & SERVICE
CEO:
Mark A. Thierer
Employees:
4,500
1600 MCCONNOR PARKWAY, SCHAUMBURG, IL 60173-6801
800-282-3232

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 3.13 Million
P/E Ratio36.2781 Dividend Yield0.0 EPS1.64
Price to Revenue0.5455 Debt to Equity0.2632 EBITDA837.706 Million
Price to Book Value2.3007 Operating Margin2.6987 Enterprise Value12.912 Billion
Current Ratio1.378 EPS Growth0.233 Quick Ratio0.937
1 Yr BETA 1.0079 52-week High/Low 0.0 / Profit Margin1.7483
Operating Cash Flow Growth9.7473 Free Cash Flow to Firm (FCFF) TTM 238.415 Million Free Cash Flow to Equity (FCFE) TTM413.985 Million
Altman Z-Score4.6681

Are you looking for this stock instead?

View SEC Filings from CTRX instead.

View recent insider trading info

CATAMARAN CORP COM STK (CDA) YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CTRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTRX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOLDEN BETSY D

  • Director
 No longer subject to file 2015-07-23 0

KRAEMER HARRY M JANSEN JR

  • Director
 0 2015-07-23 0

KATEN KAREN L

  • Director
 No longer subject to file 2015-07-23 0

COSLER STEVEN D

  • Director
 No longer subject to file 2015-07-23 0

DAVIS WILLIAM J

  • Director
 No longer subject to file 2015-07-23 0

EPSTEIN STEVEN B

  • Director
 No longer subject to file 2015-07-23 0

THIERER MARK PRESIDENT & CEO

  • Officer
 No longer subject to file 2015-07-23 0

BENSEN PETER J

  • Director
 No longer subject to file 2015-07-23 0

PARK JEFFREY G EVP, OPERATIONS

  • Officer
 No longer subject to file 2015-07-23 0

ROMZA JOHN CHIEF TECH OFFICER & EVP

  • Officer
 No longer subject to file 2015-07-23 0

MASSO ANTHONY

  • Director
 No longer subject to file 2015-07-23 0

BERMAN CLIFFORD E SVP, GENERAL COUNSEL

  • Officer
  • CORPORATE SECRETARY
 No longer subject to file 2015-07-23 0

SABAN JOEL EVP, PHARMACY OPERATIONS

  • Officer
 No longer subject to file 2015-07-23 0

SHAPIRO MICHAEL H. SVP & CHIEF FINANCIAL OFFICER

  • Officer
 No longer subject to file 2015-07-23 0

BATES RICHARD A EVP, MARKET SEGMENTS

  • Officer
 0 2012-08-06 0

THORNE CURTIS

  • Director
 No longer subject to file 2012-07-02 0

REDDON PHILIP

  • Director
 No longer subject to file 2012-07-02 0

BURKE TERRENCE C

  • Director
 No longer subject to file 2011-12-14 0

BENNOF MIKE H EVP, HEALTHCARE INFO TECH

  • Officer
 30,486 2010-07-02 0

BUSCETTO BRUCE GREG EVP & GENERAL MANAGER,INF. RX

  • Officer
 0 2009-08-12 0

GLENN GORDON S

  • FORMER CHAIRMAN
 No longer subject to file 2009-02-03 0

MEYER MICHAEL T SVP, SALES AND MARKETING

  • Officer
 0 2008-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments